Effectiveness of Stimulant Medications on Disruptive Behavior and Mood Problems in Young Children

키워드

참고문헌 (56)

1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders : DSM-5" (2013), American Psychiatric Association
2. Soonjo Hwang, "Dysfunctional Social Reinforcement Processing in Disruptive Behavior Disorders: An Functional Magnetic Resonance Imaging Study", Clinical Psychopharmacology and Neuroscience, 16(4), pp.449~460 (2018), 대한정신약물학회[DOI]
3. Connor DF, "A review of attention-deficit", hyperactivity disorder complicated by symptoms of oppositional defiant disorder or conduct disorder, 2010, pp.31, 427~440
4. Becker SP, "Co-occurring mental health problems and peer functioning among youth with attention-deficit", hyperactivity disorder : a review and recommendations for future research, 2012, pp.15, 279~302
5. Willcutt EG, "Psychiatric comorbidity associated with DSM-IV ADHD in a nonreferred sample of twins", J Am Acad Child Adolesc Psychiatry, 38, pp.1355~1362 (1999)
6. Biederman J, "Severity of the aggression", anxiety-depression, J Dev Behav Pediatr, pp.2012, 33[DOI]
7. Masi G, "Child behaviour checklist emotional dysregulation profiles in youth with disruptive behaviour disorders : clinical correlates and treatment implications", Psychiatry Res, 225, pp.191~196 (2015)
8. Zenglein Y, "Empirically determined, psychopathological subtypes in children with ADHD", J Atten Disord, 20, pp.96~107 (2016)
9. Van der Oord S, "Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD : a meta-analysis", Clin Psychol Rev, 28, pp.783~800 (2008)
10. Nock MK, "Prevalence, subtypes, and correlates of DSM-IV conduct disorder in the National Comorbidity Survey Replication", Psychol Med, 36, pp.699~710 (2006)
11. Leibenluft E, "The developmental psychopathology of irritability", Dev Psychopathol, 25(4 Pt 2), pp.1473~1487 (2013)
12. Avenevoli S, "Irritability in youth : an update", J Am Acad Child Adolesc Psychiatry, 54, pp.881~883 (2015)
13. Kutcher S, "International consensus statement on attention-deficit", hyperactivity disorder(ADHD)and disruptive behaviour disorders(DBDs) : clinical implications and treatment practice suggestions, 2004, pp.14, 11~28
14. Ollendick TH, "Parent management training and collaborative & proactive solutions : a randomized control trial for oppositional youth", J Clin Child Adolesc Psychol, 45, pp.591~604 (2016)
15. Waschbusch DA, "Effects of methylphenidate and behavior modification on the social and academic behavior of children with disruptive behavior disorders : the moderating role of callous", unemotional traits, 2007, pp.36, 629~644
16. Steiner H, "Practice parameter for the assessment and treatment of children and adolescents with oppositional defiant disorder", J Am Acad Child Adolesc Psychiatry, 46, pp.126~141 (2007)
17. Myrthala Juárez-Treviño, "Clozapine in the Treatment of Aggression in Conduct Disorder in Children and Adolescents: A Randomized, Double-blind, Controlled Trial", Clinical Psychopharmacology and Neuroscience, 17(1), pp.43~53 (2019), 대한정신약물학회[DOI]
18. Pliszka S, "Practice parameter for the assessment and treatment of children and adolescents with attention-deficit", hyperactivity disorder, 2007, pp.46, 894~921
19. Brestan EV, "Effective psychosocial treatments of conduct-disordered children and adolescents : 29 years, 82studies, and 5, 272 kids", J Clin Child Psychol, 27, pp.180~189 (1998)
20. Kazdin AE, "Parent management training: treatment for oppositional, aggressive, and antisocial behavior in children and adolescents" (2005), Oxford University Press
21. Langberg JM, "Does long-term medication use improve the academic outcomes of youth with attention-deficit", hyperactivity disorder?, 2012, pp.15, 215~233
22. Pringsheim T, "The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine", Can J Psychiatry, 60, pp.42~51 (2015)
23. Connor DF, "Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt", covert aggression-related behaviors in ADHD, 2002, pp.41, 253~261
24. Klein RG, "Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder", Arch Gen Psychiatry, 54, pp.1073~1080 (1997)
25. Kutlu A, "Effect of methylphenidate on emotional dysregulation in children with attention-deficit", hyperactivity disorder + oppositional defiant disorder, J Clin Psychopharmacol, pp.2017, 37[DOI]
26. Criteria for distinguishing effectiveness from efficacy trials in systematic reviews, "Gartlehner G", Agency for Healthcare Research and Quality, ~ (2006)
27. Pelham WE, "The effectiveness of short-and long-acting stimulant medications for adolescents with ADHD in a naturalistic secondary school setting", J Atten Disord, 21, pp.40~45 (2017)
28. Smith BH, "Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention-deficit hyperactivity disorder", Exp Clin Psychopharmacol, 6, pp.187~204 (1998)
29. Insel T, "Research domain criteria(RDoC) : toward a new classification framework for research on mental disorders", Am J Psychiatry, 167, pp.748~751 (2010)
30. Cuthbert BN, "Toward the future of psychiatric diagnosis : the seven pillars of RDoC", BMC Med, 11, pp.126~ (2013)
31. Subcommittee on Attention-Deficit, "Hyperactivity Disorder", ADHD : clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit, Pediatrics, pp.2011, 128[DOI]
32. Greenhill L, "Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD", J Am Acad Child Adolesc Psychiatry, 45, pp.1284~1293 (2006)
33. Vitiello B, "Psychopharmacology for young children : clinical needs and research opportunities", Pediatrics, 108, pp.983~989 (2001)
34. Zito JM, "Trends in the prescribing of psychotropic medications to preschoolers", JAMA, 283, pp.1025~1030 (2000)
35. Gleason MM, "Psychopharmacological treatment for very young children : contexts and guidelines", J Am Acad Child Adolesc Psychiatry, 46, pp.1532~1572 (2007)
36. Bronfenbrenner U, "Making human beings human : bioecological perspectives on human development" (2005), Sage Publications
37. Bronfenbrenner U, "Nature-nurture reconceptualized in developmental perspective : a bioecological model", Psychol Rev, 101, pp.568~586 (1994)
38. Patterson GR, "Antisocial boys: a social interactional approach" (1992), Castalia Publishing Company
39. Achenbach TM, "Achenbach system of empirically based assessment (ASEBA): development, findings, theory, and applications" (2009), University of Vermont, Research Center of Children, Youth & Families
40. Achenbach TM, "DSM-oriented and empirically based approaches to constructing scales from the same item pools", J Clin Child Adolesc Psychol, 32, pp.328~340 (2003)
41. Hudziak JJ, "Screening for DSM-IV externalizing disorders with the Child Behavior Checklist : a receiver-operating characteristic analysis", J Child Psychol Psychiatry, 45, pp.1299~1307 (2004)
42. Lowe LA, "Using the Child Behavior Checklist in assessing conduct disorder : issues of reliability and validity", Res Soc Work Pract, 8, pp.286~301 (1998)
43. Tseng WL, "Test-retest reliability and validity of a frustration paradigm and irritability measures", J Affect Disord, 212, pp.38~45 (2017)
44. Vitiello B, "Pharmacotherapy of the Preschool ADHD Treatment Study(PATS)children growing up", J Am Acad Child Adolesc Psychiatry, 54, pp.550~556 (2015)
45. Gadow KD, "Severely aggressive children receiving stimulant medication versus stimulant and risperidone : 12-month follow-up of the TOSCA trial", J Am Acad Child Adolesc Psychiatry, 55, pp.469~478 (2016)
46. Jacobson NS, "Clinical significance : a statistical approach to defining meaningful change in psychotherapy research", J Consult Clin Psychol, 59, pp.12~19 (1991)
47. Cook MN, "Effectiveness of an intensive outpatient program for disruptive children : initial findings", Community Ment Health J, 50, pp.164~171 (2014)
48. Burns BJ, "Effective treatment for mental disorders in children and adolescents", Clin Child Fam Psychol Rev, 2, pp.199~254 (1999)
49. Staller JA, "Psychopharmacologic treatment of aggressive preschoolers : a chart review", Prog Neuropsychopharmacol Biol Psychiatry, 31, pp.131~135 (2007)
50. Loureiro-Vieira S, "Methylphenidate effects in the young brain:friend or foe?", Int J Dev Neurosci, 60, pp.34~47 (2017)
51. Lenroot RK, "Differences in genetic and environmental influences on the human cerebral cortex associated with development during childhood and adolescence", Hum Brain Mapp, 30, pp.163~174 (2009)
52. Blair RJ, "Disruptive behavior disorders : taking an RDoC(ish)approach", Curr Top Behav Neurosci, 16, pp.319~336 (2014)
53. Hwang S, "Dual neurocircuitry dysfunctions in disruptive behavior disorders : emotional responding and response inhibition", Psychol Med, 46, pp.1485~1496 (2016)
54. Frick PJ, "Developmental pathways to conduct disorder : implications for future directions in research, assessment, and treatment", J Clin Child Adolesc Psychol, 41, pp.378~389 (2012)
55. Wilens TE, "Mechanism of action of agents used in attention-deficit", hyperactivity disorder, 2006, pp.67(Suppl 8), 32~38
56. Loy JH, "Atypical antipsychotics for disruptive behaviour disorders in children and youths", Cochrane Database Syst Rev, 8, pp.CD008559~ (2017)

관련 논문AI추천